Pharma BD Deal Intelligence
On October 6, 2026 Clayton, Dubilier & Rice and McKesson Corporation entered a definitive agreement to acquire Option Care Health, Inc. for $32.05 per share in cash, an enterprise value of approximately $5.8 billion and roughly a 37% premium to the prior day's close. CD&R will hold a majority interest of approximately 51% and McKesson a minority interest of approximately 49%, with McKesson investing about $1.4 billion. Option Care Health will continue to operate as a separate company under its existing management team. The agreement also sets a framework under which McKesson could eventually acquire CD&R's stake, subject to specified conditions and regulatory approvals. Closing is expected in the first half of calendar 2027. NOTE: the deals schema records a single buyer; CD&R is recorded as the majority acquirer and McKesson's 49% co-investment is captured here.
← Browse all deals · How we score deals
More: 2026 deals